• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于预测腹膜透析患者低Kt/V的列线图的开发与验证

Development and validation of a nomogram for predicting low Kt/V in peritoneal dialysis patients.

作者信息

Zhang Danfeng, Zhao Tian, Gao Liting, Zhu Huan, Jin Haowei, Liu Guiling, Wang Deguang

机构信息

Department of Nephrology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.

Institute of Kidney Disease, Inflammation & Immunity-mediated Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.

出版信息

BMC Nephrol. 2025 May 2;26(1):223. doi: 10.1186/s12882-025-04124-0.

DOI:10.1186/s12882-025-04124-0
PMID:40316989
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12046862/
Abstract

BACKGROUND

This study aimed to develop a nomogram to predict peritoneal dialysis (PD) adequacy in incident PD patients and identify those at high risk for low Kt/Vurea PD function.

METHODS

We retrospectively analyzed 141 incident PD patients from January 2021 to January 2024. Baseline characteristics, including BMI, hemoglobin levels, and high transport PD membrane, were compared between patients with and without adequate PD function. Univariate logistic regression, LASSO analysis, and Random Forest (RF) algorithms were employed to identify potential biomarkers. Significant predictors were integrated into a multivariable logistic regression model to construct a predictive nomogram.

RESULTS

The study found that 32.1% of patients had low total Kt/Vurea. Significant predictors of low Kt/Vurea included smoking (OR 2.23, CI 1.47-5.85), BMI (OR 1.35, CI 1.17-1.59), hemoglobin levels (OR 0.98, CI 0.95-0.99), and High transport (OR 0.2., CI 0.04-0.72). These factors were incorporated into a nomogram, which demonstrated strong predictive accuracy, with a C-Index of 0.802 in the main study group. The model's AUC was 0.778 (95% CI: 0.686-0.870), and Decision Curve Analysis (DCA) confirmed its clinical utility across a wide range of threshold probabilities.

CONCLUSIONS

We developed a nomogram that accurately predicts PD total Kt/Vurea in incident PD patients. This model can be a valuable tool for identifying patients at risk of low PD total Kt/Vurea, facilitating timely interventions to improve patient outcomes.

摘要

背景

本研究旨在开发一种列线图,以预测新发腹膜透析(PD)患者的腹膜透析充分性,并识别那些腹膜尿素清除率(Kt/Vurea)低的高风险患者。

方法

我们回顾性分析了2021年1月至2024年1月期间的141例新发腹膜透析患者。比较了腹膜透析功能充分和不充分患者的基线特征,包括体重指数(BMI)、血红蛋白水平和高转运腹膜透析膜。采用单因素逻辑回归、LASSO分析和随机森林(RF)算法来识别潜在的生物标志物。将显著的预测因素纳入多变量逻辑回归模型,以构建预测列线图。

结果

研究发现,32.1%的患者总Kt/Vurea较低。Kt/Vurea低的显著预测因素包括吸烟(比值比[OR]2.23,可信区间[CI]1.47 - 5.85)、BMI(OR 1.35,CI 1.17 - 1.59)、血红蛋白水平(OR 0.98,CI 0.95 - 0.99)和高转运(OR 0.2,CI 0.04 - 0.72)。这些因素被纳入列线图,该列线图显示出强大的预测准确性,在主要研究组中的C指数为0.802。该模型的曲线下面积(AUC)为0.778(95%CI:0.686 - 0.870),决策曲线分析(DCA)证实了其在广泛阈值概率范围内的临床实用性。

结论

我们开发了一种列线图,可准确预测新发腹膜透析患者的腹膜透析总Kt/Vurea。该模型可作为识别腹膜透析总Kt/Vurea低风险患者的有价值工具,有助于及时进行干预以改善患者预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3110/12046862/fd32aba7afc3/12882_2025_4124_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3110/12046862/95d144d93b44/12882_2025_4124_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3110/12046862/72b3e0492093/12882_2025_4124_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3110/12046862/da4b5d3e20cb/12882_2025_4124_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3110/12046862/d91b2ce85df8/12882_2025_4124_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3110/12046862/9c667c7ea495/12882_2025_4124_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3110/12046862/fd32aba7afc3/12882_2025_4124_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3110/12046862/95d144d93b44/12882_2025_4124_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3110/12046862/72b3e0492093/12882_2025_4124_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3110/12046862/da4b5d3e20cb/12882_2025_4124_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3110/12046862/d91b2ce85df8/12882_2025_4124_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3110/12046862/9c667c7ea495/12882_2025_4124_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3110/12046862/fd32aba7afc3/12882_2025_4124_Fig6_HTML.jpg

相似文献

1
Development and validation of a nomogram for predicting low Kt/V in peritoneal dialysis patients.用于预测腹膜透析患者低Kt/V的列线图的开发与验证
BMC Nephrol. 2025 May 2;26(1):223. doi: 10.1186/s12882-025-04124-0.
2
Serum cystatin C for estimation of residual renal function in children on peritoneal dialysis.血清胱抑素 C 用于估计腹膜透析儿童的残余肾功能。
Pediatr Nephrol. 2011 Mar;26(3):433-40. doi: 10.1007/s00467-010-1678-8. Epub 2010 Nov 11.
3
Low-Sodium Versus Standard-Sodium Peritoneal Dialysis Solution in Hypertensive Patients: A Randomized Controlled Trial.低钠与标准钠腹膜透析液在高血压患者中的应用:一项随机对照试验。
Am J Kidney Dis. 2016 May;67(5):753-61. doi: 10.1053/j.ajkd.2015.07.031. Epub 2015 Sep 20.
4
Nomogram to Estimate the Risk of Chronic Kidney Disease-Associated Pruritus in Patients with End-Stage Renal Disease Undergoing Peritoneal Dialysis: Model Development and Validation Study.列线图评估腹膜透析终末期肾病患者慢性肾脏病相关瘙痒风险:模型建立和验证研究。
Blood Purif. 2024;53(9):755-767. doi: 10.1159/000539786. Epub 2024 Jun 20.
5
Development and validation of a nomogram for predicting refractory peritoneal dialysis related peritonitis.开发并验证了一种列线图模型,用于预测难治性腹膜透析相关性腹膜炎。
Ren Fail. 2024 Dec;46(2):2368083. doi: 10.1080/0886022X.2024.2368083. Epub 2024 Jul 3.
6
Volume-Based Peritoneal Dialysis Prescription Guide to Achieve Adequacy Targets.基于容量的腹膜透析处方指南以实现充分性目标。
Perit Dial Int. 2016 Mar-Apr;36(2):188-95. doi: 10.3747/pdi.2014.00255. Epub 2015 Aug 20.
7
Adequacy testing in peritoneal dialysis: a five years experience in a single dialysis center.腹膜透析充分性检测:一家透析中心的五年经验
Neth J Med. 1999 Apr;54(4):147-51. doi: 10.1016/s0300-2977(99)00002-9.
8
Estimation of residual glomerular filtration rate and renal Kt/Vurea from creatinine clearance in end-stage renal disease patients. The Netherlands Cooperative Study on the Adequacy of Dialysis.根据终末期肾病患者的肌酐清除率估算残余肾小球滤过率和肾尿素清除率。荷兰透析充分性合作研究。
Adv Perit Dial. 1999;15:132-7.
9
Solute Clearance and Fluid Removal: Large-Dose Cyclic Tidal Peritoneal Dialysis.溶质清除与液体清除:大剂量间歇性腹膜透析。
Ther Apher Dial. 2019 Apr;23(2):180-186. doi: 10.1111/1744-9987.12765. Epub 2018 Oct 24.
10
Resting energy expenditure: a valuable predictor for KT/Vurea in peritoneal dialysis patients
.静息能量消耗:腹膜透析患者尿素清除率(KT/Vurea)的重要预测指标
Clin Nephrol. 2017 Sep;88(9):124-131. doi: 10.5414/CN109042.

本文引用的文献

1
The Role of Kt/V and Creatinine Clearance on Assisting Optimization of Serum Phosphorus Levels among Patients on Peritoneal Dialysis.Kt/V和肌酐清除率在协助优化腹膜透析患者血清磷水平中的作用
Kidney360. 2025 Jan 1;6(1):105-111. doi: 10.34067/KID.0000000618. Epub 2024 Oct 11.
2
Development and validation of a nomogram for predicting refractory peritoneal dialysis related peritonitis.开发并验证了一种列线图模型,用于预测难治性腹膜透析相关性腹膜炎。
Ren Fail. 2024 Dec;46(2):2368083. doi: 10.1080/0886022X.2024.2368083. Epub 2024 Jul 3.
3
A time-averaged serum bicarbonate-based nomogram to predict the probability of residual kidney function preservation for patients undergoing peritoneal dialysis.
基于血清碳酸氢盐时间平均的列线图预测行腹膜透析患者残余肾功能保留的概率。
Eur Rev Med Pharmacol Sci. 2024 Mar;28(6):2305-2316. doi: 10.26355/eurrev_202403_35734.
4
ML-CKDP: Machine learning-based chronic kidney disease prediction with smart web application.ML-CKDP:基于机器学习的慢性肾病预测与智能网络应用程序
J Pathol Inform. 2024 Feb 22;15:100371. doi: 10.1016/j.jpi.2024.100371. eCollection 2024 Dec.
5
Development and validation of a nomogram for predicting gram-negative bacterial infections in patients with peritoneal dialysis-associated peritonitis.预测腹膜透析相关性腹膜炎患者革兰氏阴性菌感染的列线图的开发与验证
Heliyon. 2023 Jul 23;9(8):e18551. doi: 10.1016/j.heliyon.2023.e18551. eCollection 2023 Aug.
6
Association between gut microbial diversity and technique failure in peritoneal dialysis patients.肠微生物多样性与腹膜透析患者技术失败的关系。
Ren Fail. 2023 Dec;45(1):2195014. doi: 10.1080/0886022X.2023.2195014.
7
The Correlation between Serum Lipoprotein(a) and Risk of Mortality in Patients on Peritoneal Dialysis.血清脂蛋白(a)与腹膜透析患者死亡风险的相关性。
Clin Lab. 2022 Aug 1;68(8). doi: 10.7754/Clin.Lab.2022.220102.
8
Kt/V reach rate is associated with clinical outcome in incident peritoneal dialysis patients.Kt/V 达标率与新进入腹膜透析患者的临床结局相关。
Ren Fail. 2022 Dec;44(1):482-489. doi: 10.1080/0886022X.2022.2048854.
9
A visual risk assessment tool for acute kidney injury after intracranial aneurysm clipping surgery.一种用于颅内动脉瘤夹闭术后急性肾损伤的视觉风险评估工具。
Ren Fail. 2020 Nov;42(1):1093-1099. doi: 10.1080/0886022X.2020.1838299.
10
Technique Failure in Peritoneal Dialysis: Etiologies and Risk Assessment.腹膜透析技术失败:病因与风险评估。
Blood Purif. 2021;50(1):42-49. doi: 10.1159/000508159. Epub 2020 Jul 17.